Glucose Variability With DPP-4 Inhibition
NCT01751321
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
Sitagliptin, placebo
Sponsor
Research Clinical Centre of the Russian Railways, JSC